semaglutide news today 2025 New in the August 14, 2025, issue of NEJM: Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 phase 3a trial) https://nej.md/444aW7f Cagrilintide–Semaglutide for Overweight and Diabetes (REDEFINE 2 phase 3a trial) https://nej.md/4ehQwLk Type 2 diabetes drug improves
Pay in 4 interest-free payments of $6.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16





















![MOUNJARO, MOUNJARO Kwikpen 2.5mg/0.6ml [PRESCRIPTION REQUIRED] Available in Click & CollectMOUNJARO Kwikpen 2.5mg/0.6ml [PRESCRIPTION REQUIRED] Available in Click & Collect](https://medias.watsons.com.ph/publishing/50057683%20MOUNJARO%202.5mg%20%28BOX%29%20121525-EZpCnjWv-zoom.png?version=1767689123)






